3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
37
Head and Neck Neoplasms
28
Prostatic Neoplasms
16
Oropharyngeal Neoplasms
11
Carcinoma, Non-Small-Cell Lung
10
Uterine Cervical Neoplasms
8
Gliosarcoma
8
Glioblastoma
8
Carcinoma, Squamous Cell
7
Brain Neoplasms
7
Tongue Neoplasms
6
Rectal Neoplasms
6
Pancreatic Neoplasms
5
Lung Neoplasms
5
Laryngeal Neoplasms
5
Astrocytoma
5
Papillomavirus Infections
4
Neoplasm Metastasis
4
Mouth Neoplasms
4
Sarcoma
3
Neoplasms
3
Hypopharyngeal Neoplasms
3
Glioma
3
Carcinoma
3
Breast Neoplasms
3
Urinary Bladder Neoplasms
2
Thyroid Carcinoma, Anaplastic
2
Stomatitis
2
Rhabdomyosarcoma
2
Radiation Injuries
2
Interventions
pembrolizumab
3
Axitinib
2
regorafenib
1
avelumab
1
amivantamab
1
Tretinoin
1
Specimen Handling
1
Radiation
1
Pemetrexed
1
Nelfinavir
1
Magnetic Resonance Spectroscopy
1
Glutamate Carboxypeptidase II
1
GSK-3326595
1
Etoposide
1
Endoscopic Mucosal Resection
1
Doxorubicin
1
Cisplatin
1
Bortezomib
1
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Adenoid Cystic
×
Radiotherapy, Intensity-Modulated
×
Clear all
No trials found.